Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 3,639 Shares of Company Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,639 shares of the company’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $130.37, for a total value of $474,416.43. Following the completion of the transaction, the chief executive officer directly owned 473,825 shares in the company, valued at approximately $61,772,565.25. The trade was a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

CVSA stock traded down $1.02 during midday trading on Friday, reaching $129.27. The stock had a trading volume of 195,878 shares, compared to its average volume of 365,483. The firm has a fifty day simple moving average of $128.36 and a two-hundred day simple moving average of $123.69. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market cap of $4.38 billion, a PE ratio of 18.36, a P/E/G ratio of 0.94 and a beta of 0.65.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, equities research analysts anticipate that Adtalem Global Education Inc. will post 9 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CVSA shares. Weiss Ratings downgraded shares of Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Sunday, September 27th. Truist Financial downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a report on Thursday, September 3rd. Finally, BMO Capital Markets cut their price objective on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a research note on Monday. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Hold” and an average target price of $151.67.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management acquired a new position in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by institutional investors and hedge funds.

About Adtalem Global Education

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.